Penicillin G Dosing for Group B Streptococcus
For intrapartum GBS prophylaxis, administer penicillin G 5 million units IV as an initial loading dose, followed by 2.5-3.0 million units IV every 4 hours until delivery. 1, 2
Dosing Regimen Details
Standard Protocol
- Loading dose: 5 million units IV initially 1, 2
- Maintenance dose: 2.5-3.0 million units IV every 4 hours until delivery 1, 2
- The range of 2.5-3.0 million units is specifically designed to achieve adequate drug levels in fetal circulation and amniotic fluid while avoiding neurotoxicity 1
- Choose the dose within this range based on which penicillin G formulations are readily available in your pharmacy to reduce the need for special preparation 1
Route of Administration
- Intravenous administration is the only acceptable route for GBS prophylaxis, as it achieves the necessary high concentrations in maternal and fetal circulation 2
Pharmacokinetic Rationale
Timing Considerations
- Optimal prophylaxis requires at least 4 hours of antibiotic administration before delivery to maximize effectiveness 1
- However, even shorter durations provide benefit: fetal penicillin G levels exceed the minimum inhibitory concentration (MIC) for GBS by 10-179 fold, even with brief exposure 3
- Penicillin G levels increase linearly for the first hour after administration, then decrease rapidly according to a power-decay model 3
- The drug does not accumulate in cord blood with maintenance dosing and returns to baseline after each 4-hour interval 3
Dosing Interval Justification
- The 4-hour dosing interval is critical because average serum penicillin concentration drops to approximately 12 mcg/mL after 4 hours, necessitating redosing to maintain anti-GBS activity 4
- More frequent dosing does not increase antimicrobial activity 4
Alternative First-Line Agent
Ampicillin
- Dosing: 2 g IV initial dose, then 1 g IV every 4 hours until delivery 2, 5
- Ampicillin is an acceptable alternative, though penicillin G is preferred due to its narrower spectrum of activity, which reduces selection pressure for resistant organisms 2
Penicillin-Allergic Patients
Risk Stratification Required
- High-risk for anaphylaxis is defined as history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration 1, 2
For Patients NOT at High Risk for Anaphylaxis
- Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery 2, 5, 6
- Approximately 10% of penicillin-allergic patients will cross-react with cephalosporins, making risk assessment essential 5, 6
For Patients at High Risk for Anaphylaxis
- Clindamycin: 900 mg IV every 8 hours until delivery (only if GBS isolate is susceptible to both clindamycin and erythromycin) 2, 5, 6
- Vancomycin: 1 g IV every 12 hours until delivery (if susceptibility testing unavailable or isolate is resistant to clindamycin) 2, 5, 6
- Susceptibility testing is mandatory for penicillin-allergic patients at high risk for anaphylaxis, as clindamycin resistance rates have increased to 3-15% in the US 2
- Testing for inducible clindamycin resistance is necessary for isolates susceptible to clindamycin but resistant to erythromycin 1, 2
Critical Clinical Pitfalls
What NOT to Do
- Never use erythromycin for GBS prophylaxis in penicillin-allergic patients at high risk for anaphylaxis, as it is no longer acceptable due to resistance rates up to 20.2% 1, 2
- Do not treat GBS colonization before the intrapartum period with antimicrobials, as this is ineffective in eliminating carriage and may promote resistance 5
- Do not delay medically necessary obstetric procedures to achieve 4 hours of prophylaxis, though timing procedures to allow adequate prophylaxis is preferred when possible 1
Special Populations
- Women with GBS bacteriuria at any concentration during pregnancy require both treatment of the UTI and intrapartum prophylaxis during labor, regardless of whether they were treated earlier in pregnancy 5
- The risk of anaphylaxis with penicillin (4/10,000 to 4/100,000 recipients) is far outweighed by the benefits of preventing GBS disease 2